Joel Mases
jmasesbcn.bsky.social
Joel Mases
@jmasesbcn.bsky.social
Segarrenc de Guissona. Radiation Oncologist MD. GU and hepatic cancer at Hospital Clínic. Barcelona. #radonc
Reposted by Joel Mases
November 18, 2024 at 1:54 AM
Reposted by Joel Mases
Ever wondered if urethral dose explained the differential GU toxicity by platform in PACE-B? It appears not- credit to Dr Ragu Ratnakumaran @ijrobp.bsky.social

eur01.safelinks.protection.outlook.com?url=https%3A...
ScienceDirect.com | Science, health and medical journals, full text articles and books.
eur01.safelinks.protection.outlook.com
January 24, 2025 at 4:00 PM
Reposted by Joel Mases
When even the WSJ Editorial Board has this to say
www.wsj.com/opinion/rfk-...
January 27, 2025 at 2:42 PM
Reposted by Joel Mases
Coffee drinking timing and mortality in US adults

"Drinking coffee in the morning may be more strongly associated with a lower risk of mortality than drinking coffee later in the day."

academic.oup.com/eurheartj/ad...
January 13, 2025 at 5:02 AM
Reposted by Joel Mases
Systematic review & meta-analysis of locoregional therapies for #HCC in @jama.com network open

✅Inclusion:
RCTs with PFS and OS as endpoints

✅Conclusions:
Resection > thermal ablation ~ RT ~ HAIC > embolization

#oncsky #radonc #radsky #liversky

ja.ma/3ONRpQ1
Locoregional Therapies for Hepatocellular Carcinoma
This systematic review and meta-analysis compares findings from randomized clinical trials on the use of locoregional therapies as monotherapy or combination therapy in the treatment of nonmetastatic ...
ja.ma
December 6, 2024 at 12:45 PM